ESC Premium Access

Impact of digoxin use on adverse outcomes in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study in China

Topic: Atrial fibrillation (AF)

Congress Presentation

About the speaker

Miss Shuang Wu

Fuwai Hospital, CAMS and PUMC, Beijing (China)
0 follower

24 more presentations in this session

Rate-control treatment and clinical outcomes in patients with atrial fibrillation and obstructive lung disease

Speaker: Doctor S. You (Seoul, KR)


Efficacy of acute intravenous therapy with potassium, magnesium and metoprolol in recent-onset atrial fibrillation

Speaker: Miss A. Moser (Hamburg, DE)


Postoperative atrial fibrillation in patients with reduced ejection fraction heart failure undergoing cardiac surgery: ranolazine shortens time to conversion when added to amiodarone

Speaker: Professor J. Skoularigis (Larissa, GR)


INR prior to bleeding is below 3.0 most of the time in patients with atrial fibrillation using warfarin

Speaker: Doctor P. Oliveira Guimaraes (Durham, US)


Antiarrhythmic effect of the anti-influenza drug oseltamivir in an experimental whole-heart model of atrial fibrillation

Speaker: Doctor C. Ellermann (Muenster, DE)


Access the full session

Poster session 3 - Drug treatment

Speakers: Miss S. Wu, Doctor S. You, Miss A. Moser, Professor J. Skoularigis, Doctor P. Oliveira Guimaraes...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb